Prevalence of nodal metastases in the individual lymph node stations for different T-stages in gastric cancer: a systematic review - Scorecard - MDSpire
Advertisement
Prevalence of nodal metastases in the individual lymph node stations for different T-stages in gastric cancer: a systematic review
Clinical Scorecard: Distribution of Nodal Metastases Across Lymph Node Stations by T-Stage in Gastric Cancer: A Systematic Review
At a Glance
Category
Detail
Condition
Gastric cancer with lymph node metastases
Key Mechanisms
Tumor invasion depth (T-stage) correlates with prevalence and distribution of lymph node metastases; extent of lymphadenectomy influences recurrence and survival
Target Population
Patients with operable gastric cancer undergoing surgical treatment
Care Setting
Surgical oncology and gastroenterology clinical settings
Key Highlights
Gastric cancer remains the fifth most common cancer worldwide and third leading cause of cancer mortality.
Lymph node involvement strongly influences recurrence rates (20%-50%) and prognosis in gastric cancer.
Extent of lymphadenectomy (D1 vs D2) impacts loco-regional recurrence, survival, and surgical morbidity/mortality.
Guideline-Based Recommendations
Diagnosis
Use AJCC 7th edition for T-stage classification in gastric cancer.
Classify lymph node stations per Japanese Gastric Cancer Association system.
Assess nodal metastases prevalence per individual lymph node station by T-stage.
Management
Perform D1 lymphadenectomy for T1a tumors and well-differentiated, <1.5 cm T1b tumors not meeting endoscopic resection criteria.
Consider D2 lymphadenectomy for more advanced T-stages to reduce loco-regional recurrence and improve survival.
Endoscopic resection is feasible for early gastric tumors meeting strict criteria (e.g., T1a, well-differentiated, ≤2 cm, non-ulcerated).
Monitoring & Follow-up
Monitor for recurrence given high rates post-gastrectomy, especially in patients with lymph node involvement.
Balance risk of lymph node metastases with surgical morbidity when deciding extent of lymphadenectomy.
Risks
D2 lymphadenectomy is associated with higher morbidity (43%-46%) and mortality (10%-13%) compared to D1 lymphadenectomy.
Risk of lymph node metastases increases substantially from T1 (8%-31%) to T2-T4 tumors (45%-90%).
Patient & Prescribing Data
Patients with operable gastric cancer stratified by T-stage
Tailored lymphadenectomy extent based on T-stage and tumor characteristics balances oncologic benefit and surgical risk.
Clinical Best Practices
Use multidisciplinary approach incorporating tumor biology, stage, and location to guide extent of lymphadenectomy.
Apply Japanese Gastric Cancer Association lymph node station classification for surgical planning.
Consider endoscopic resection for early-stage tumors meeting established criteria to avoid unnecessary surgery.
Perform systematic quality assessment of studies when reviewing evidence to inform clinical decisions.